ROS Scavenger Decreases Basal Perfusion Pressure, Vasoconstriction and NO Synthase Activity in Pulmonary Circulation During Pulmonary Microembolism

Abstract

Two mechanisms contribute in the development of pulmonary hypertension in pulmonary embolism (PE) -obstruction of pulmonary blood vessels and vasoconstriction. We hypothesize that hypoxia, increased shear stress and/or activation of gathered leukocytes in the PE may cause a release of reactive oxygen species (ROS). Therefore our aim was to determine the influence of the ROS scavenger Tempol on pulmonary hypertension and to describe NO synthase activity and production of NO oxidative products (NOx) after PE. In general anesthesia sephadex microspheres suspended in PSS were applied in right jugular vein as the pulmonary microembolism.Than we measured in isolated salt solution-perfused lungs the changes in perfusion pressure, activity of NO synthase and NOx plasma concentration in 7 groups of rats: C: control group (n=5), CN: C + sodium nitroprusside (SN) (n=5), EN: PE + SN (n=5), ETN: Tempol + PE + SN (n=5), CL: C + L-NAME (n=5), EL: PE + L-NAME (n=5), ETL: Tempol + PE + L-NAME (n=5). Tempol was applied intraperitoneally before PE. Animals that received Tempol (groups TN, TL) had significantly lower basal perfusion pressure than those which did not receive Tempol (EN, EL). Overall we measured a higher decrease of perfusion pressure than in the control group (C) after application of SN. Administration of L-NAME after PE (EL) increased the pressure more than in the control group (NL). NOx concentration was higher after PE. We found that preventive administration of Tempol decreases the increase in perfusion pressure after PE. PE increased NO release and concentration of NOx. Key words ROS scavenger • Pulmonary hypertension • Pulmonary embolism• Nitric oxide • Free radicals Corresponding authorR. Mizera, Traumatologicko-ortopedické centrum KNL a.s.,

Increasing angiotensin-converting enzyme (ACE) 2/ACE axes ratio alleviates early pulmonary vascular remodeling in a porcine model of acute pulmonary embolism with cardiac arrest

“…In this study, we described endothelial proliferation and World J Emerg Med, Vol 13, No 3, 2022 The endothelial dysfunction triggers vascular remodeling, which leads to the formation of PAH. [15] The pathological characteristics of pulmonary endothelial dysfunction in PAH include disordered proliferation, abnormal intimal thickening, and the formation of fibrotic, plexiform, concentric, and dilation/angiomatoid lesions. Plexiform lesions are formed by irregular endothelial cell masses and sparse myofibroblasts.…”

Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems

“…When Sephadex microspheres suspended in PSS were applied in right jugular vein as the pulmonary microembolism, thechanges in perfusion pressure in isolated salt solution-perfused lungs, the activity of NO synthase and NOx plasma concentration were measured in rats. Tempol was applied intraperitoneally before pulmonary embolism which demonstrates the significant reduction in the basal perfusion pressure[58].The selective pulmonary vasodilation effect of soluble guanylate cyclase and a low dose of 5-Cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine (BAY 41-2272) has been reported in dogs with an acute pulmonary embolism. Evaluation of arterial blood gas and hemodynamic were carried out in non-embolized vehicle treated dogs and in embolized dogs treated with intravenous injections of BAY 41-2272 microspheres.…”